Potential serological biomarkers of cerebral malaria

Disease Markers

Volumn 31, Issue 6, 2011, Pages 327-335

  Lucchi, Naomi W ^a,b   Jain, Vidhan ^c   Wilson, Nana O ^d   Singh, Neeru ^c   Udhayakumar, Venkatachalam ^a,b   Stiles, Jonathan K ^d  

^a ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c National Institute of Malaria Research   (India)

^d MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; cerebral malaria; malaria; severe malaria

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANTIMALARIAL AGENT; CXCL9 CHEMOKINE; ERYTHROPOIETIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 8; QUININE; RANTES; TUMOR NECROSIS FACTOR RECEPTOR 2; VASCULOTROPIN;

ANEMIA; APOPTOSIS; AREA UNDER THE CURVE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN MALARIA; CEREBROSPINAL FLUID ANALYSIS; CLINICAL PRACTICE; COGNITION; COMATOSE PATIENT; CONVULSION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DISEASE TRANSMISSION; ENDOTHELIUM CELL; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HUMAN; IMMUNITY; INFECTION RISK; INTENSIVE CARE; MALARIA CONTROL; MICROGLIA; MOLECULAR DIAGNOSIS; MORTALITY; NERVE CELL; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; NONHUMAN; OUTCOME ASSESSMENT; PATIENT CARE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME; RETINOPATHY; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEROLOGY; SURVIVAL;

EID: 84255182432     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0854     Document Type: Review

References (61)

1. M.S. Pepe, R. Etzioni, Z. Feng, J.D. Potter, M.L. Thompson et al., Phases of biomarker development for early detection of cancer, J Natl Cancer Inst 93 (2001), 1054-1061. (Pubitemid 32717537)
2. S.G. Coca and C.R. Parikh, Urinary biomarkers for acute kidney injury: perspectives on translation, Clin J Am Soc Nephrol 3 (2008), 481-490.
3. World Malaria Report, 2008. World Health Organization.
4. F.N. Baliraine, Y.A. Afrane, D.A. Amenya, M. Bonizzoni, D.M. Menge et al., High prevalence of asymptomatic plasmodium falciparum infections in a highland area of western Kenya: a cohort study, J Infect Dis 200 (2009), 66-74.
5. S. Mabunda, J.J. Aponte, A. Tiago and P. Alonso, A countrywide malaria survey in Mozambique. II. Malaria attributable proportion of fever and establishment of malaria case definition in children across different epidemiological settings, Malar J 8 (2009), 74.
6. M. Vafa, M. Troye-Blomberg, J. Anchang, A. Garcia and F. Migot-Nabias, Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants, Malar J 7 (2008), 17.
7. M.P. Dal-Bianco, K.B. Koster, U.D. Kombila, J.F. Kun, M.P. Grobusch et al., High prevalence of asymptomatic Plasmodium falciparum infection in Gabonese adults, Am J Trop Med Hyg 77 (2007), 939-942. (Pubitemid 351837845)
8. W.P. O'Meara, P. Bejon, T.W. Mwangi, E.A. Okiro, N. Peshu et al., Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya, Lancet 372 (2008), 1555-1562.
9. M.J. Barcus, H. Basri, H. Picarima, C. Manyakori, Sekartuti et al., Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua, Am J Trop Med Hyg 77 (2007), 984-991. (Pubitemid 351837852)
10. B. Genton, V. D'Acremont, L. Rare, K. Baea, J.C. Reeder et al., Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea, PLoS Med 5 (2008), e127.
11. D.K. Kochar, A. Das, S.K. Kochar, V. Saxena, P. Sirohi et al., Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India, Am J Trop Med Hyg 80 (2009), 194-198.
12. D.K. Kochar, S.K. Kochar, R.P. Agrawal, M. Sabir, K.C. Nayak et al., The changing spectrum of severe falciparum malaria: a clinical study from Bikaner (northwest India), J Vector Borne Dis 43 (2006), 104-108. (Pubitemid 44517756)
13. D.K.Kochar, D. Pakalapati, S.K.Kochar, P. Sirohi, M.P. Khatri et al., An unexpected cause of fever and seizures, Lancet 370 (2007), 908. (Pubitemid 47364802)
14. D.K. Kochar, V. Saxena, N. Singh, S.K. Kochar, S.V. Kumar et al., Plasmodium vivax malaria, Emerg Infect Dis 11 (2005), 132-134. (Pubitemid 40093368)
15. M.K. Mohapatra, K.N. Padhiary, D.P. Mishra and G. Sethy, Atypical manifestations of Plasmodium vivax malaria, Indian J Malariol 39 (2002), 18-25. (Pubitemid 37484204)
16. J. Prakash, A.K. Singh, N.S. Kumar and R.K. Saxena, Acute renal failure in Plasmodium vivax malaria, J Assoc Physicians India 51 (2003), 265-267. (Pubitemid 44242115)
17. E. Tjitra, N.M. Anstey, P. Sugiarto, N. Warikar, E. Kenangalem et al.,Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia, PLoS Med 5 (2008), e128.
18. B. Ogutu, A.B. Tiono, M. Makanga, Z. Premji, A.D. Gbadoe et al., Treatment of asymptomatic carriers with artemetherlumefantrine: an opportunity to reduce the burden of malaria? Malar J 9, 30.
19. R. Idro, K. Marsh, C.C. John and C.R. Newton, Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome, Pediatr Res 68 (2008), 267-274.
20. M.J. Boivin, P. Bangirana, J. Byarugaba, R.O. Opoka, R. Idro et al., Cognitive impairment after cerebral malaria in children: a prospective study, Pediatrics 119 (2007), e360-366. (Pubitemid 46397732)
21. J.A. Carter, J.A. Lees, J.K. Gona, G. Murira, K. Rimba et al., Severe falciparum malaria and acquired childhood language disorder, Dev Med Child Neurol 48 (2006), 51-57. (Pubitemid 43124457)
22. J.A. Carter, A.J. Ross, B.G. Neville, E. Obiero, K. Katana et al., Developmental impairments following severe falciparum malaria in children, Trop Med Int Health 10 (2005), 3-10. (Pubitemid 40193680)
23. R. Idro, J.A. Carter, G. Fegan, B.G. Neville and C.R. Newton, Risk factors for persisting neurological and cognitive impairments following cerebral malaria, Arch Dis Child 91 (2006), 142-148. (Pubitemid 43362519)
24. V. Mung'Ala-Odera, R.W. SnowandC.R.Newton, The burden of the neurocognitive impairment associated with Plasmodium falciparum malaria in sub-saharan Africa, Am J TropMed Hyg 71 (2004), 64-70. (Pubitemid 39121305)
25. A.M. Dondorp, C.I. Fanello, I.C. Hendriksen, E. Gomes, A. Seni et al., Artesunate versus quinine in the treatment of severe falciparummalaria inAfrican children (AQUAMAT): an openlabel, randomised trial, Lancet 376, 1647-1657.
26. T.E. Taylor, W.J. Fu, R.A. Carr, R.O. Whitten, J.S. Mueller et al., Differentiating the pathologies of cerebral malaria by postmortem parasite counts, Nat Med 10 (2004), 143-145. (Pubitemid 38524882)
27. H. Armah, A.K. Dodoo, E.K. Wiredu, J.K. Stiles, A.A. Adjei et al., High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria, Ann Trop Med Parasitol 99 (2005), 629-647. (Pubitemid 41503825)
28. I.A. Clark, K.A. Rockett and W.B. Cowden, Role of TNF in cerebral malaria, Lancet 337 (1991), 302-303.
29. B.Y. Sarfo, S. Singh, J.W. Lillard, Jr., A. Quarshie, R.K. Gyasi et al., The cerebral-malaria-associated expression of RANTES, CCR3 and CCR5 in post-mortem tissue samples, Ann Trop Med Parasitol 98 (2004), 297-303. (Pubitemid 38594739)
30. H.B. Armah, N.O. Wilson, B.Y. Sarfo, M.D. Powell, V.C. Bond et al., Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children, Malar J 6 (2007), 147.
31. V. Jain, H.B. Armah, J.E. Tongren, R.M. Ned, N.O.Wilson et al., Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India, Malar J 7 (2008), 83.
32. N.A. Beare, C. Southern, C. Chalira, T.E. Taylor, M.E. Molyneux et al., Prognostic significance and course of retinopathy in children with severe malaria, Arch Ophthalmol 122 (2004), 1141-1147. (Pubitemid 39031129)
33. C. Hirneiss, V. Klauss, M. Wilke, A. Kampik, T. Taylor et al., Ocular changes in tropical malaria with cerebral involvementresults from the Blantyre Malaria Project], Klin Monbl Augenheilkd 222 (2005), 704-708. (Pubitemid 41413720)
34. S. Lewallen, H. Bakker, T.E. Taylor, B.A. Wills, P. Courtright et al., Retinal findings predictive of outcome in cerebral malaria, Trans R Soc Trop Med Hyg 90 (1996), 144-146. (Pubitemid 26141083)
35. S. Lewallen, T.E. Taylor, M.E. Molyneux, B.A. Wills and P. Courtright, Ocular fundus findings in Malawian children with cerebral malaria, Ophthalmology 100 (1993), 857-861. (Pubitemid 23163495)
36. D.K.Kochar, Shubhakaran, B.L.Kumawat, I. Thanvi, A. Joshi et al., Ophthalmoscopic abnormalities in adults with falciparum malaria, QJM 91 (1998), 845-852. (Pubitemid 29027071)
37. D.K. Kochar, Shubhakaran, B.L. Kumawat and S.P. Vyas, Prognostic significance of eye changes in cerebral malaria, J Assoc Physicians India 48 (2000), 473-477.
38. N.A. Beare, T.E. Taylor, S.P. Harding, S. Lewallen and M.E. Molyneux, Malarial retinopathy: a newly established diagnostic sign in severe malaria, Am J Trop Med Hyg 75 (2006), 790-797. (Pubitemid 351627520)
39. C.C. John, A. Panoskaltsis-Mortari, R.O. Opoka, G.S. Park, P.J. Orchard et al., Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria, Am J Trop Med Hyg 78 (2008), 198-205. (Pubitemid 351844547)
40. C.C. John, R. Opika-Opoka, J. Byarugaba, R. Idro and M.J. Boivin, Low levels of RANTES are associated with mortality in children with cerebral malaria, J Infect Dis 194 (2006), 837-845. (Pubitemid 44344133)
41. A.L. Conroy, E.I. Lafferty, F.E. Lovegrove, S. Krudsood, N. Tangpukdee et al., Whole blood angiopoietin-1 and -2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malaria, Malar J 8 (2009), 295.
42. F.E. Lovegrove, N. Tangpukdee, R.O. Opoka, E.I. Lafferty, N. Rajwans et al., Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children, PLoS One 4 (2009), e4912.
43. N.O.Wilson, V. Jain, C.E. Roberts, N. Lucchi, P.K. Joel et al., CXCL4 and CXCL10 predict risk of fatal cerebral malaria, Dis Markers 30, 39-49.
44. P. Bangirana, B. Giordani, C.C. John, C. Page, R.O. Opoka et al., Immediate neuropsychological and behavioral benefits of computerized cognitive rehabilitation in Ugandan pediatric cerebral malaria survivors, J Dev Behav Pediatr 30 (2009), 310-318.
45. A.L. Siren and H. Ehrenreich, Erythropoietin - a novel concept for neuroprotection, Eur Arch Psychiatry Clin Neurosci 251 (2001), 179-184. (Pubitemid 32963495)
46. A.L. Siren, M. Fratelli, M. Brines, C. Goemans, S. Casagrande et al., Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress, Proc Natl Acad Sci U S A 98 (2001), 4044-4049. (Pubitemid 32249895)
47. C. Casals-Pascual, R. Idro, N. Gicheru, S. Gwer, B. Kitsao et al., High levels of erythropoietin are associated with protection against neurological sequelae inAfrican childrenwith cerebral malaria, Proc Natl Acad Sci U S A 105 (2008), 2634-2639. (Pubitemid 351520565)
48. M. Bernaudin, A. Bellail, H.H. Marti, A. Yvon, D. Vivien et al., Neurons and astrocytes express EPO mRNA: oxygensensing mechanisms that involve the redox-state of the brain, Glia 30 (2000), 271-278. (Pubitemid 30259666)
49. M.L. Brines, P. Ghezzi, S. Keenan, D. Agnello, N.C. de Lanerolle et al., Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury, Proc Natl Acad Sci U S A 97 (2000), 10526-10531.
50. G.S. Campanella, A.M. Tager, J.K. El Khoury, S.Y. Thomas, T.A. Abrazinski et al., Chemokine receptor CXCR3 and its ligands CXCL9 andCXCL10 are required for the development of murine cerebral malaria, Proc Natl Acad Sci U S A 105 (2008), 4814-4819. (Pubitemid 351753829)
51. C.Q. Nie, N.J. Bernard, M.U. Norman, F.H. Amante, R.J. Lundie et al., IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection, PLoS Pathog 5 (2009), e1000369.
52. T. Hayashi, K. Deguchi, S. Nagotani, H. Zhang, Y. Sehara et al., Cerebral ischemia and angiogenesis, Curr Neurovasc Res 3 (2006), 119-129. (Pubitemid 43764788)
53. C. Casals-Pascual, R. Idro, S. Picot, D.J. Roberts and C.R. Newton, Can erythropoietin be used to prevent brain damage in cerebral malaria? Trends Parasitol 25 (2009), 30-36.
54. L. Wiese, C. Hempel, M. Penkowa, N. Kirkby and J.A. Kurtzhals, Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria, Malar J 7 (2008), 3.
55. S. Picot and A.L. Bienvenu, Plasmodium vivax infection: not so benign], Med Sci (Paris) 25 (2009), 622-626.
56. P.J. van Genderen, I.M. van der Meer, J. Consten, P.L. Petit, T. van Gool et al., Evaluation of plasma lactate as a parameter for disease severity on admission in travelers with Plasmodium falciparum malaria, J Travel Med 12 (2005), 261-264. (Pubitemid 43074387)
57. P.L.Witt, G.T. Spear, M.J. Lindstrom, H.A. Kessler, E.C. Borden et al., 2′,5′-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals, AIDS 5 (1991), 289-293.
58. N.W. Lucchi, A. Demas, J. Narayanan, D. Sumari, A.Kabanywanyi et al., Real-time fluorescence loop mediated isothermal amplification for the diagnosis of malaria, PLoS ONE 5, e13733.
59. W.G. Lee, Y.G. Kim, B.G. Chung and U. Demirci, Khademhosseini A Nano/Microfluidics for diagnosis of infectious diseases in developing countries, Adv Drug Deliv Rev 62, 449-457.
60. L.K. Erdman, A. Dhabangi, C. Musoke, A.L. Conroy, M. Hawkes et al., Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study, PLoS ONE 6, e17440.
61. T.W. Yeo, D.A. Lampah, R. Gitawati, E. Tjitra, E. Kenangalem et al., Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria, Proc Natl Acad Sci U S A 105 (2008), 17097-17102.